Seastar Medical Holding CORP Form 4 insider transactions

SeaStar Medical Holding Corp CEO Eric Schlorff was granted 10,288 restricted stock units, with vesting scheduled over the next two years.

SeaStar Medical Holding Corp reports a restricted stock unit award granted to Chief Medical Officer Kevin Chung, with vesting scheduled over multiple dates.

SeaStar Medical Holding Corp reports a restricted stock unit award to Director Bernadette N. Vincent, with vesting scheduled for July 1, 2027.

SeaStar Medical Holding Corp reports a transaction where Director John Neuman acquired 4,000 restricted stock units.

SeaStar Medical Holding Corp reports a transaction where Director Kenneth Van Heel acquired 4,000 restricted stock units.

Director Jennifer A. Baird acquired 4,000 restricted stock units of SeaStar Medical Holding Corp. on July 1, 2026, with full vesting expected on July 1, 2027.

SeaStar Medical Holding Corp Director Kenneth Van Heel was granted 3,000 Restricted Stock Units, vesting fully on February 6, 2027.

SeaStar Medical Holding Corp. Director John Neuman received an award of 3,000 Restricted Stock Units, vesting fully on February 6, 2027.

SeaStar Medical Holding Corp. Director Bernadette N. Vincent received an award of 3,000 Restricted Stock Units, vesting fully on February 6, 2027.

SeaStar Medical Holding Corp. Director Jennifer A. Baird received an award of 3,000 Restricted Stock Units (RSUs) on February 6, 2026, which will vest in full on February 6, 2027.

SeaStar Medical's Principal Accounting Officer, Bradford K. Towne, was granted 7,500 restricted stock units vesting over three years.

SeaStar Medical Holding Corp's Chief Medical Officer, Kevin Chung, was granted 15,000 Restricted Stock Units, aligning management interests with shareholders.

SeaStar Medical Holding Corp's CEO, Eric Schlorff, was granted 30,000 Restricted Stock Units (RSUs) vesting over three years.

SeaStar Medical Holding Corp. director Jennifer A. Baird acquired 4,200 shares of common stock at $0.2351 per share.

SeaStar Medical Holding Corp's Chief Financial Officer, Michael Messinger, acquired 14,500 shares of common stock at $0.3516 per share.

SeaStar Medical Holding Corp Director Kenneth Van Heel acquired 35,000 shares of common stock over two days in late August 2025.

SeaStar Medical Holding Corp's Chief Medical Officer, Kevin Chung, purchased 10,000 shares of common stock at $0.80 per share.

SeaStar Medical Holding Corp. Director Jennifer A. Baird was granted 4,000 restricted stock units, vesting fully by July 3, 2026.

SeaStar Medical Holding Corp. Director John Neuman increased his beneficial ownership to 92,000 shares through the vesting of 2,667 restricted stock units and the grant of an additional 4,000 restricted stock units.

SeaStar Medical Holding Corp. Director Bernadette N. Vincent reported the vesting of 2,667 restricted stock units and the grant of an additional 4,000 restricted stock units, increasing her total beneficial ownership to 12,000 shares.

SeaStar Medical Holding Corp. Director Kenneth Van Heel disclosed the vesting of 4,000 restricted stock units and the grant of an additional 4,000 restricted stock units, with all share amounts adjusted for a recent 1-for-25 reverse stock split.

SeaStar Medical Holding Corp's Chief Medical Officer, Kevin Chung, reported the vesting of 5,000 restricted stock units and the reclassification of 25,000 unvested RSUs, increasing his direct beneficial ownership to 48,184 shares.

SeaStar Medical Holding Corp.'s CEO, Eric Schlorff, reported the vesting of 21,667 restricted stock units into common stock, adjusting his beneficial ownership to 98,517 shares following a 1-for-25 reverse stock split.

SeaStar Medical Holding Corp. Director Jennifer A. Baird increased her beneficial ownership of common stock through the vesting of restricted stock units and an open market purchase in June 2025.

SeaStar Medical Holding Corp. Director John Neuman purchased 40,000 shares of common stock at a weighted average price of $0.3599, increasing his beneficial ownership to 80,000 shares.

Director Jennifer Baird purchased 10,000 shares of SeaStar Medical Holding Corp at a weighted average price of $1.2815 on May 20, 2025.

Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp, recently purchased 4,500 shares of common stock at $1.25 per share.

Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp, reports the acquisition of 15,000 Restricted Stock Units (RSUs) on April 1, 2025, vesting over three years.

David A. Green, CFO of SeaStar Medical Holding Corp, reports the acquisition of 15,000 restricted stock units (RSUs) on April 1, 2025.

Director John Neuman has been steadily increasing his holdings in SeaStar Medical through a series of open market purchases.